,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,22077,311,Drug Gene Interaction database (DGIdb),Citric Acid,,CITRIC ACID,https://www.dgidb.org/drugs/CITRIC ACID,,ALDH1A1,https://www.dgidb.org/genes/ALDH1A1,,,216.0,ALDH1A1,9606.0,Homo sapiens (human),,,,,,,,
1,22078,311,Therapeutic Target Database (TTD),Citric Acid,D02RTS,citric acid,https://idrblab.net/ttd/data/drug/details/D02RTS,T64213,Transient receptor potential cation channel V4 (TRPV4),https://idrblab.net/ttd/data/target/details/T64213,Q9HBA0,Transient receptor potential cation channel subfamily V member 4,59341.0,TRPV4,9606.0,Homo sapiens (human),Activator,,,,,,,
2,22079,311,Therapeutic Target Database (TTD),Citric Acid,D02RTS,citric acid,https://idrblab.net/ttd/data/drug/details/D02RTS,T18978,Polycystic kidney disease 2-like 1 (TRPP2),https://idrblab.net/ttd/data/target/details/T18978,Q9P0L9,Polycystic kidney disease 2-like 1 protein,9033.0,PKD2L1,9606.0,Homo sapiens (human),Activator,,,,,,,
3,26804,311,Drug Gene Interaction database (DGIdb),Citric Acid,,CITRIC ACID,https://www.dgidb.org/drugs/CITRIC ACID,,NFE2L2,https://www.dgidb.org/genes/NFE2L2,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
4,32135,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0000747,Aldose reductase,https://www.drugbank.ca/bio_entities/BE0000747,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:8117658|PMID:17505104,https://www.ncbi.nlm.nih.gov/pubmed/8117658|https://www.ncbi.nlm.nih.gov/pubmed/17505104,8117658|17505104,,"Harrison DH, Bohren KM, Ringe D, Petsko GA, Gabbay KH: An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate. Biochemistry. 1994 Mar 1;33(8):2011-20. doi: 10.1021/bi00174a006.|Biadene M, Hazemann I, Cousido A, Ginell S, Joachimiak A, Sheldrick GM, Podjarny A, Schneider TR: The atomic resolution structure of human aldose reductase reveals that rearrangement of a bound ligand allows the opening of the safety-belt loop. Acta Crystallogr D Biol Crystallogr. 2007 Jun;63(Pt 6):665-72. Epub 2007 May 15."
5,32136,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0001524,Isocitrate dehydrogenase [NADP],https://www.drugbank.ca/bio_entities/BE0001524,P39126,Isocitrate dehydrogenase [NADP],938183.0,icd,224308.0,Bacillus subtilis subsp. subtilis str. 168,Substrate|Inhibitor,,,PMID:10996257|PMID:6636842|PMID:25229866,https://www.ncbi.nlm.nih.gov/pubmed/10996257|https://www.ncbi.nlm.nih.gov/pubmed/6636842|https://www.ncbi.nlm.nih.gov/pubmed/25229866,10996257|6636842|25229866,,"Sadka A, Dahan E, Or E, Cohen L: NADP(+)-isocitrate dehydrogenase gene expression and isozyme activity during citrus fruit development. Plant Sci. 2000 Sep 8;158(1-2):173-181. doi: 10.1016/s0168-9452(00)00328-9.|Agrawal PK, Bhatt CS, Viswanathan L: Inhibition of fungal NADP+-isocitrate dehydrogenase by citric acid. Z Allg Mikrobiol. 1983;23(6):403-6. doi: 10.1002/jobm.3630230613.|Kobayashi K, Hattori T, Hayashi R, Kirimura K: Overexpression of the NADP+-specific isocitrate dehydrogenase gene (icdA) in citric acid-producing Aspergillus niger WU-2223L. Biosci Biotechnol Biochem. 2014;78(7):1246-53. doi: 10.1080/09168451.2014.918483. Epub 2014 Jun 17."
6,32137,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0001482,Beta-lactamase,https://www.drugbank.ca/bio_entities/BE0001482,P00808,Beta-lactamase,56670005.0,blaP,1402.0,Bacillus licheniformis,Weak inhibitor,,,PMID:18515103,https://www.ncbi.nlm.nih.gov/pubmed/18515103,18515103,,"Beck J, Sauvage E, Charlier P, Marchand-Brynaert J: 2-Aminopropane-1,2,3-tricarboxylic acid: Synthesis and co-crystallization with the class A beta-lactamase BS3 of Bacillus licheniformis. Bioorg Med Chem Lett. 2008 Jul 1;18(13):3764-8. doi: 10.1016/j.bmcl.2008.05.045. Epub 2008 May 16."
7,32138,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0001426,Beta-lactamase 2,https://www.drugbank.ca/bio_entities/BE0001426,P04190,Metallo-beta-lactamase type 2,,,1396.0,Bacillus cereus,,,,PMID:5784217,https://www.ncbi.nlm.nih.gov/pubmed/5784217,5784217,,"Coles NW, Gross R: Exopenicillinase synthesis in Staphylococcus aureus. J Bacteriol. 1969 May;98(2):659-61."
8,32139,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0004459,"Citrate synthase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0004459,O75390,"Citrate synthase, mitochondrial",1431.0,CS,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
9,32140,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0000838,Proto-oncogene tyrosine-protein kinase Src,https://www.drugbank.ca/bio_entities/BE0000838,P12931,Proto-oncogene tyrosine-protein kinase Src,6714.0,SRC,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
10,32328,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003317,Ribonuclease pancreatic,https://www.drugbank.ca/bio_entities/BE0003317,P07998,Ribonuclease pancreatic,6035.0,RNASE1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
11,32329,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0000908,Eosinophil cationic protein,https://www.drugbank.ca/bio_entities/BE0000908,P12724,Eosinophil cationic protein,6037.0,RNASE3,9606.0,Homo sapiens (human),,,,,,,,Structure Of Ecp In Complex With Citrate Ions
12,32330,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0001914,Fumarate hydratase class II,https://www.drugbank.ca/bio_entities/BE0001914,P05042,Fumarate hydratase class II,946147.0,fumC,83333.0,Escherichia coli K-12,Inhibitor,,,PMID:8909293,https://www.ncbi.nlm.nih.gov/pubmed/8909293,8909293,,"Weaver T, Banaszak L: Crystallographic studies of the catalytic and a second site in fumarase C from Escherichia coli. Biochemistry. 1996 Nov 5;35(44):13955-65."
13,32331,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003257,Carboxypeptidase B,https://www.drugbank.ca/bio_entities/BE0003257,P15086,Carboxypeptidase B,1360.0,CPB1,9606.0,Homo sapiens (human),,,,,,,,
14,32332,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0001966,6-phosphogluconolactonase,https://www.drugbank.ca/bio_entities/BE0001966,Q9X0N8,6-phosphogluconolactonase,,,243274.0,Thermotoga maritima MSB8,,,,PMID:19345229,https://www.ncbi.nlm.nih.gov/pubmed/19345229,19345229,,"Duclert-Savatier N, Poggi L, Miclet E, Lopes P, Ouazzani J, Chevalier N, Nilges M, Delarue M, Stoven V: Insights into the enzymatic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei using structural data and molecular dynamics simulation. J Mol Biol. 2009 May 22;388(5):1009-21. doi: 10.1016/j.jmb.2009.03.063. Epub 2009 Apr 1."
15,32333,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003259,Beta-fructosidase,https://www.drugbank.ca/bio_entities/BE0003259,O33833,Beta-fructosidase,,,243274.0,Thermotoga maritima MSB8,,,,,,,,
16,32334,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0002953,Intron-associated endonuclease 1,https://www.drugbank.ca/bio_entities/BE0002953,P13299,Intron-associated endonuclease 1,1258722.0,I-TevI,10665.0,Escherichia virus T4,,,,,,,,
17,32335,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0004434,U6 snRNA-associated Sm-like protein LSm6,https://www.drugbank.ca/bio_entities/BE0004434,P62312,U6 snRNA-associated Sm-like protein LSm6,11157.0,LSM6,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
18,32336,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003262,Pleckstrin homology domain-containing family A member 1,https://www.drugbank.ca/bio_entities/BE0003262,Q9HB21,Pleckstrin homology domain-containing family A member 1,59338.0,PLEKHA1,9606.0,Homo sapiens (human),,,,,,,,
19,32337,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003263,Fe(3+)-binding periplasmic protein,https://www.drugbank.ca/bio_entities/BE0003263,P21408,Fe(3+)-binding periplasmic protein,,,615.0,Serratia marcescens,,,,,,,,
20,32534,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0002611,Nicotinate-nucleotide adenylyltransferase,https://www.drugbank.ca/bio_entities/BE0002611,P0A753,Nicotinate-nucleotide adenylyltransferase,1027549.0,nadD,623.0,Shigella flexneri,,,,,,,,
21,32535,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003265,N utilization substance protein B homolog,https://www.drugbank.ca/bio_entities/BE0003265,Q9X286,Transcription antitermination protein NusB,,,243274.0,Thermotoga maritima MSB8,,,,,,,,
22,32536,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003266,Complement component C8 gamma chain,https://www.drugbank.ca/bio_entities/BE0003266,P07360,Complement component C8 gamma chain,733.0,C8G,9606.0,Homo sapiens (human),,,,,,,,
23,32537,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003256,50S ribosomal protein L4,https://www.drugbank.ca/bio_entities/BE0003256,P38516,50S ribosomal protein L4,,,243274.0,Thermotoga maritima MSB8,,,,,,,,
24,32538,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003258,Hexon protein,https://www.drugbank.ca/bio_entities/BE0003258,P03277,Hexon protein,2652998.0,L3,10515.0,Human adenovirus 2,,,,,,,,
25,32539,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0002555,Glutamine synthetase,https://www.drugbank.ca/bio_entities/BE0002555,P9WN38,Glutamine synthetase,45426197.0,glnA,83331.0,Mycobacterium tuberculosis CDC1551,,,,,,,,
26,32540,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003261,RNA 3'-terminal phosphate cyclase,https://www.drugbank.ca/bio_entities/BE0003261,P46849,RNA 3'-terminal phosphate cyclase,2847707.0,rtcA,83333.0,Escherichia coli K-12,,,,,,,,
27,32541,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003121,Prostaglandin F synthase,https://www.drugbank.ca/bio_entities/BE0003121,Q9GV41,"9,11-endoperoxide prostaglandin H2 reductase",,,5702.0,Trypanosoma brucei brucei,,,,,,,,
28,32542,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0000115,Adenine phosphoribosyltransferase,https://www.drugbank.ca/bio_entities/BE0000115,P07741,Adenine phosphoribosyltransferase,353.0,APRT,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
29,32543,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0002555,Glutamine synthetase,https://www.drugbank.ca/bio_entities/BE0002555,P9WN39,Glutamine synthetase,45426197.0,glnA,83332.0,Mycobacterium tuberculosis H37Rv,,,,,,,,
30,32544,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0002545,GMP synthase [glutamine-hydrolyzing],https://www.drugbank.ca/bio_entities/BE0002545,P04079,GMP synthase [glutamine-hydrolyzing],947334.0,guaA,83333.0,Escherichia coli K-12,,,,,,,,
31,32545,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0004443,Inosine triphosphate pyrophosphatase,https://www.drugbank.ca/bio_entities/BE0004443,Q9BY32,Inosine triphosphate pyrophosphatase ,3704.0,ITPA,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
32,32546,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003267,Ribonucleoside-diphosphate reductase subunit beta,https://www.drugbank.ca/bio_entities/BE0003267,Q9CBQ2,Ribonucleoside-diphosphate reductase subunit beta,,,272631.0,Mycobacterium leprae TN,,,,,,,,
33,32690,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003271,"3-carboxy-cis,cis-muconate cycloisomerase",https://www.drugbank.ca/bio_entities/BE0003271,P32427,"3-carboxy-cis,cis-muconate cycloisomerase",,,303.0,Pseudomonas putida,,,,,,,,
34,32691,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003268,Ribose-5-phosphate isomerase A,https://www.drugbank.ca/bio_entities/BE0003268,P44725,Ribose-5-phosphate isomerase A,,,71421.0,Haemophilus influenzae Rd KW20,,,,,,,,
35,32692,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0001042,Solute carrier organic anion transporter family member 2B1,https://www.drugbank.ca/bio_entities/BE0001042,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:12724351,https://www.ncbi.nlm.nih.gov/pubmed/12724351,12724351,,"Kobayashi D, Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I: Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane. J Pharmacol Exp Ther. 2003 Aug;306(2):703-8. Epub 2003 Apr 30."
36,32693,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003272,Pyruvate decarboxylase,https://www.drugbank.ca/bio_entities/BE0003272,P06672,Pyruvate decarboxylase,,,264203.0,Zymomonas mobilis subsp. mobilis ZM4 = ATCC 31821,,,,,,,,
37,32694,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0002757,Laccase domain protein YfiH,https://www.drugbank.ca/bio_entities/BE0002757,P33644,Purine nucleoside phosphorylase YfiH,947089.0,yfiH,83333.0,Escherichia coli K-12,,,,,,,,
38,32695,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0004566,L-amino-acid oxidase,https://www.drugbank.ca/bio_entities/BE0004566,Q96RQ9,L-amino-acid oxidase,259307.0,IL4I1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
39,32696,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0004551,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,https://www.drugbank.ca/bio_entities/BE0004551,Q9GZU7,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,58190.0,CTDSP1,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
40,32697,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0004625,Hepatocyte growth factor-regulated tyrosine kinase substrate,https://www.drugbank.ca/bio_entities/BE0004625,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,9146.0,HGS,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
41,32698,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003253,Invasin,https://www.drugbank.ca/bio_entities/BE0003253,P11922,Invasin,,,273123.0,Yersinia pseudotuberculosis IP 32953,,,,,,,,
42,32861,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0009973,Metallo-beta-lactamase type 2,https://www.drugbank.ca/bio_entities/BE0009973,C7C422,Metallo-beta-lactamase type 2,75186374.0,KXJ80_RS01030,573.0,Klebsiella pneumoniae,Inhibitor,,,PMID:29749367,https://www.ncbi.nlm.nih.gov/pubmed/29749367,29749367,,"Kumar R, Chandar B, Parani M: Use of succinic & oxalic acid in reducing the dosage of colistin against New Delhi metallo-beta-lactamase-1 bacteria. Indian J Med Res. 2018 Jan;147(1):97-101. doi: 10.4103/ijmr.IJMR_1407_16."
43,32862,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003254,Short tail fiber protein gp12,https://www.drugbank.ca/bio_entities/BE0003254,P10930,Short tail fiber protein gp12,1258789.0,12,10665.0,Escherichia virus T4,,,,,,,,
44,32863,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0000780,"Malate dehydrogenase, mitochondrial",https://www.drugbank.ca/bio_entities/BE0000780,P40926,"Malate dehydrogenase, mitochondrial",,,9606.0,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
45,32864,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0002690,2-methylcitrate synthase,https://www.drugbank.ca/bio_entities/BE0002690,O34002,2-methylcitrate synthase,,,56673.0,Antarctic bacterium DS2-3R,,,,,,,,
46,32865,311,DrugBank,Citric Acid,DB04272,Citric acid,https://www.drugbank.ca/drugs/DB04272,BE0003269,Lysozyme,https://www.drugbank.ca/bio_entities/BE0003269,Q37875,SAR-endolysin,2777454.0,lyz,2886926.0,Escherichia phage P1,,,,,,,,
47,49519,311,Drug Gene Interaction database (DGIdb),Citric Acid,,CITRIC ACID,https://www.dgidb.org/drugs/CITRIC ACID,,PLIN1,https://www.dgidb.org/genes/PLIN1,,,5346.0,PLIN1,9606.0,Homo sapiens (human),,,,,,,,
48,49803,311,BindingDB,Citric Acid,14672,"2-hydroxypropane-1,2,3-tricarboxylic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=14672,1558,Proto-oncogene tyrosine-protein kinase Src (aa 145-252),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1558,,,,,,,,IC50 (nM),>40000000,PMID:14613321,https://www.ncbi.nlm.nih.gov/pubmed/14613321,14613321,,
49,49804,311,IUPHAR/BPS Guide to PHARMACOLOGY,Citric Acid,2478,citric acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2478,510,TRPV4,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=510,Q9EPK8,Transient receptor potential cation channel subfamily V member 4 ,63873.0,Trpv4,10090.0,Mus musculus (house mouse),Agonist,pEC50,5.6,PMID:12692122,https://www.ncbi.nlm.nih.gov/pubmed/12692122,12692122,,
50,51604,311,Drug Gene Interaction database (DGIdb),Citric Acid,,CITRIC ACID,https://www.dgidb.org/drugs/CITRIC ACID,,KDM4A,https://www.dgidb.org/genes/KDM4A,,,9682.0,KDM4A,9606.0,Homo sapiens (human),,,,,,,,
51,51605,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,9606.0,Homo sapiens (human),Capsazepine inhibits the reaction [citric acid results in increased activity of TRPV1 protein]|citric acid results in increased activity of TRPV1 protein,,,PMID:22566028,https://www.ncbi.nlm.nih.gov/pubmed/22566028,22566028,,
52,51606,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,9606.0,Homo sapiens (human),VEGFA protein binds to citric acid analog,,,PMID:22154009,https://www.ncbi.nlm.nih.gov/pubmed/22154009,22154009,,
53,51607,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in decreased expression of BCL2L1 protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
54,51608,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,100506742,CASP12,https://ctdbase.org/detail.go?type=gene&acc=100506742,,,100506742.0,CASP12,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in increased activity of CASP12 protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
55,51656,311,IUPHAR/BPS Guide to PHARMACOLOGY,Citric Acid,2478,citric acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2478,505,TRPP2,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=505,Q9P0L9,Polycystic kidney disease 2-like 1 protein,9033.0,PKD2L1,9606.0,Homo sapiens (human),Agonist,pEC50,1.7,PMID:16891422,https://www.ncbi.nlm.nih.gov/pubmed/16891422,16891422,,
56,51758,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in increased activity of CASP3 protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
57,51759,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,50,ACO2,https://ctdbase.org/detail.go?type=gene&acc=50,,,50.0,ACO2,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in decreased activity of ACO2 protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
58,51760,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,27329,ANGPTL3,https://ctdbase.org/detail.go?type=gene&acc=27329,,,27329.0,ANGPTL3,9606.0,Homo sapiens (human),Citric acid results in increased expression of ANGPTL3 mRNA,,,PMID:27089845,https://www.ncbi.nlm.nih.gov/pubmed/27089845,27089845,,
59,51761,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in increased expression of BAX protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
60,51762,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),[silver analog co-treated with citric acid] results in increased expression of BAX mRNA,,,PMID:27021274,https://www.ncbi.nlm.nih.gov/pubmed/27021274,27021274,,
61,51763,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in decreased expression of BCL2 protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
62,51764,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[silver analog co-treated with citric acid] results in increased expression of BCL2 mRNA,,,PMID:27021274,https://www.ncbi.nlm.nih.gov/pubmed/27021274,27021274,,
63,51765,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),Quercetin inhibits the reaction [citric acid results in decreased activity of CAT protein]|citric acid results in decreased activity of CAT protein,,,PMID:24745150,https://www.ncbi.nlm.nih.gov/pubmed/24745150,24745150,,
64,51766,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),[silver analog co-treated with citric acid] results in increased secretion of CCL2 protein,,,PMID:27021274,https://www.ncbi.nlm.nih.gov/pubmed/27021274,27021274,,
65,51767,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),[silver analog co-treated with citric acid] results in decreased expression of CCNB1 mRNA,,,PMID:27021274,https://www.ncbi.nlm.nih.gov/pubmed/27021274,27021274,,
66,51768,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942.0,CD86,9606.0,Homo sapiens (human),Citric acid inhibits the reaction [imidazolidinyl urea results in increased expression of CD86 protein]|citric acid inhibits the reaction [dinitrochlorobenzene results in increased expression of CD86 protein],,,PMID:29743441,https://www.ncbi.nlm.nih.gov/pubmed/29743441,29743441,,
67,51952,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,9606.0,Homo sapiens (human),[silver analog co-treated with citric acid] affects the expression of CDK2 mRNA,,,PMID:27021274,https://www.ncbi.nlm.nih.gov/pubmed/27021274,27021274,,
68,51953,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in increased expression of CDKN1A protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
69,51954,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,1280,COL2A1,https://ctdbase.org/detail.go?type=gene&acc=1280,,,1280.0,COL2A1,10116.0,Rattus norvegicus (Norway rat),Dexamethasone inhibits the reaction [[COL2A1 protein co-treated with freund's adjuvant] results in increased abundance of citric acid]|[geniposide co-treated with phellodendrine co-treated with magnoflorine co-treated with chlorogenic acid co-treated with crocin co-treated with flavonoids co-treated with berberine alkaloids] inhibits the reaction [[COL2A1 protein co-treated with freund's adjuvant] results in increased abundance of citric acid]|[col2a1 protein co-treated with freund's adjuvant] results in increased abundance of citric acid|huang-lien-chieh-tu-tang inhibits the reaction [[COL2A1 protein co-treated with freund's adjuvant] results in increased abundance of citric acid],,,PMID:24709313,https://www.ncbi.nlm.nih.gov/pubmed/24709313,24709313,,
70,51955,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,10116.0,Rattus norvegicus (Norway rat),[citric acid co-treated with silver analog] results in decreased expression of DLG4 protein,,,PMID:25447321,https://www.ncbi.nlm.nih.gov/pubmed/25447321,25447321,,
71,51956,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,2074,ERCC6,https://ctdbase.org/detail.go?type=gene&acc=2074,,,2074.0,ERCC6,10090.0,Mus musculus (house mouse),ERCC6 gene mutant form results in decreased abundance of citric acid,,,PMID:25440059,https://www.ncbi.nlm.nih.gov/pubmed/25440059,25440059,,
72,51957,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,2746,GLUD1,https://ctdbase.org/detail.go?type=gene&acc=2746,,,2746.0,GLUD1,9606.0,Homo sapiens (human),Citric acid inhibits the reaction [aluminum chloride binds to and results in decreased activity of GLUD1 protein],,,PMID:14625697,https://www.ncbi.nlm.nih.gov/pubmed/14625697,14625697,,
73,51958,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,3141,HLCS,https://ctdbase.org/detail.go?type=gene&acc=3141,,,3141.0,HLCS,9606.0,Homo sapiens (human),Citric acid results in decreased activity of HLCS protein,,,PMID:26303405,https://www.ncbi.nlm.nih.gov/pubmed/26303405,26303405,,
74,51959,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606.0,Homo sapiens (human),Citric acid inhibits the reaction [imidazolidinyl urea results in increased expression of ICAM1 protein]|citric acid inhibits the reaction [dinitrochlorobenzene results in increased expression of ICAM1 protein],,,PMID:29743441,https://www.ncbi.nlm.nih.gov/pubmed/29743441,29743441,,
75,51960,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,25818,KLK5,https://ctdbase.org/detail.go?type=gene&acc=25818,,,25818.0,KLK5,9606.0,Homo sapiens (human),Citric acid results in increased activity of KLK5 protein,,,PMID:16517595,https://www.ncbi.nlm.nih.gov/pubmed/16517595,16517595,,
76,51961,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090.0,Mus musculus (house mouse),LEPR affects the abundance of citric acid,,,PMID:20567778,https://www.ncbi.nlm.nih.gov/pubmed/20567778,20567778,,
77,52124,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,4489,MT1A,https://ctdbase.org/detail.go?type=gene&acc=4489,,,4489.0,MT1A,10116.0,Rattus norvegicus (Norway rat),[silver analog co-treated with citric acid] results in increased expression of MT1A mRNA,,,PMID:25194297,https://www.ncbi.nlm.nih.gov/pubmed/25194297,25194297,,
78,52125,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,4586,MUC5AC,https://ctdbase.org/detail.go?type=gene&acc=4586,,,4586.0,MUC5AC,9606.0,Homo sapiens (human),Capsaicin promotes the reaction [citric acid results in increased secretion of MUC5AC protein]|capsazepine inhibits the reaction [citric acid results in increased secretion of MUC5AC protein]|citric acid results in increased secretion of MUC5AC protein,,,PMID:22566028,https://www.ncbi.nlm.nih.gov/pubmed/22566028,22566028,,
79,52126,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,10090.0,Mus musculus (house mouse),[[NR1H4 protein co-treated with dietary fats] results in increased susceptibility to caffeic acid phenethyl ester] which results in increased abundance of citric acid,,,PMID:28223344,https://www.ncbi.nlm.nih.gov/pubmed/28223344,28223344,,
80,52127,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,5213,PFKM,https://ctdbase.org/detail.go?type=gene&acc=5213,,,5213.0,PFKM,9606.0,Homo sapiens (human),Citric acid promotes the reaction [resveratrol results in decreased activity of PFKM protein],,,PMID:23454376,https://www.ncbi.nlm.nih.gov/pubmed/23454376,23454376,,
81,52128,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,30474,RX3,https://ctdbase.org/detail.go?type=gene&acc=30474,,,30474.0,rx3,7955.0,Danio rerio (zebrafish),RX3 gene mutant form results in increased abundance of citric acid,,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
82,52129,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,9058,SLC13A2,https://ctdbase.org/detail.go?type=gene&acc=9058,,,9058.0,SLC13A2,6239.0,Caenorhabditis elegans,SLC13A2 protein results in increased uptake of citric acid|lithium promotes the reaction [SLC13A2 protein results in increased uptake of citric acid]|lithium inhibits the reaction [SLC13A2 protein results in increased uptake of citric acid],,,PMID:12826022,https://www.ncbi.nlm.nih.gov/pubmed/12826022,12826022,,
83,52130,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,284111,SLC13A5,https://ctdbase.org/detail.go?type=gene&acc=284111,,,284111.0,SLC13A5,9606.0,Homo sapiens (human),SLC13A5 protein affects the uptake of citric acid,,,PMID:30054523,https://www.ncbi.nlm.nih.gov/pubmed/30054523,30054523,,
84,52131,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,28250,SLCO1A4,https://ctdbase.org/detail.go?type=gene&acc=28250,,,28250.0,Slco1a4,10090.0,Mus musculus (house mouse),SLCO1A4 protein affects the abundance of citric acid,,,PMID:21561886,https://www.ncbi.nlm.nih.gov/pubmed/21561886,21561886,,
85,52132,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,6853,SYN1,https://ctdbase.org/detail.go?type=gene&acc=6853,,,6853.0,SYN1,10116.0,Rattus norvegicus (Norway rat),[citric acid co-treated with silver analog] results in decreased expression of SYN1 protein,,,PMID:25447321,https://www.ncbi.nlm.nih.gov/pubmed/25447321,25447321,,
86,52133,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,6855,SYP,https://ctdbase.org/detail.go?type=gene&acc=6855,,,6855.0,SYP,10116.0,Rattus norvegicus (Norway rat),[citric acid co-treated with silver analog] results in decreased expression of SYP protein,,,PMID:25447321,https://www.ncbi.nlm.nih.gov/pubmed/25447321,25447321,,
87,52298,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,7015,TERT,https://ctdbase.org/detail.go?type=gene&acc=7015,,,7015.0,TERT,9606.0,Homo sapiens (human),[citric acid co-treated with zinc chloride] results in decreased activity of TERT protein,,,PMID:16624386,https://www.ncbi.nlm.nih.gov/pubmed/16624386,16624386,,
88,52299,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D019343,Citric Acid,https://ctdbase.org/detail.go?type=chem&acc=D019343,7018,TF,https://ctdbase.org/detail.go?type=gene&acc=7018,,,7018.0,TF,9606.0,Homo sapiens (human),Citric acid promotes the reaction [chromium binds to TF protein],,,PMID:1375080,https://www.ncbi.nlm.nih.gov/pubmed/1375080,1375080,,
89,59277,311,Therapeutic Target Database (TTD),Citric Acid,D02RTS,citric acid,https://idrblab.net/ttd/data/drug/details/D02RTS,T73726,Candida Cytochrome P450 51 (Candi ERG11),https://idrblab.net/ttd/data/target/details/T73726,P10613,Lanosterol 14-alpha demethylase,3641571.0,ERG11,237561.0,Candida albicans SC5314,Binder,,,,,,,
90,74135,311,Comparative Toxicogenomics Database (CTD),Citric Acid,C016600,ferrous citrate,https://ctdbase.org/detail.go?type=chem&acc=C016600,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Sodium arsenite promotes the reaction [ferrous citrate results in increased expression of HMOX1 protein]|ferrous citrate results in increased expression of HMOX1 protein|ferrous citrate promotes the reaction [sodium arsenite results in increased expression of HMOX1 protein],,,PMID:20633106,https://www.ncbi.nlm.nih.gov/pubmed/20633106,20633106,,
91,180282,311,Comparative Toxicogenomics Database (CTD),Citric Acid,D000077559,Sodium Citrate,https://ctdbase.org/detail.go?type=chem&acc=D000077559,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10116.0,Rattus norvegicus (Norway rat),Sodium citrate results in decreased expression of ABCG8 mRNA,,,PMID:27765674,https://www.ncbi.nlm.nih.gov/pubmed/27765674,27765674,,
